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Aldehyde oxidase [aldehyde: O2 oxidoreductase EC
1.2.3.1] is a large dimeric protein with a molecular weight of
approximately 300000 Da, composed of two identical sub-
units (150000 Da).1,2) Each subunit contains 1 atom of mo-
lybdenum, 1 molecule of enzyme-bound flavin adenine dinu-
cleotide (FAD), 4 atoms of non-heme iron and 4 atoms of
acid-labile sulfur.1,2) It can oxidase a wide range of substrates
including aldehydes and N-heterocyclic compounds. The re-
action catalyzed by this enzyme can be represented by the
general equation:
RH1H2O fi ROH12e
212H1
where RH and ROH are the substrate and the hydroxylated
metabolite, respectively.1,3) The reaction involves a nucle-
ophilic attack on an electron-deficient sp2-hybridized carbon
atom which may belong to aromatic azaheterocycles contain-
ing the –CH5N– moiety (such as phthalazine and purine),
aromatic or nonaromatic charged azaheterocycles containing
the –CH5N1, moiety (e.g., N 1-methylnicotinamide and N-
methylphthalazinium) or aldehydes containing the –CH5O
moiety (such as benzaldehyde and vanillin).4) Aldehyde oxi-
dase is widely distributed throughout the animal kingdom
and many studies have been carried out using the enzyme
prepared from various species. As this cytosolic enzyme is
involved in the oxidation of the important compounds famci-
clovir,5) methotrexate,6) azathioprine,7) quinine,8,9) quini-
dine,9) carbazeran,10) allopurinol,11) pyridoxal,12) and N1-
methylnicotinamide,12) an understanding of the manner of the
interactions of aldehyde oxidase with its substrates would be
useful in the design of efficient substrates or potent inhibitors
for this enzyme. However, there is no report on the detailed
study of the physicochemical requirements of aldehyde oxi-
dase-substrate interactions. In order to obtain a better under-
standing of these interactions at the molecular level, in the
present study, structure–activity relationships of some N-het-
erocyclic substrates of aldehyde oxidase including phtha-
lazine and quinazoline derivatives were investigated quantita-
tively. The reaction schemes of phthalazine and quinazoline
to the corresponding oxidation products are shown in Chart
1.
Experimental
The kinetic constants (Km and Vmax) were available for 14 phthalazine and
15 quinazoline derivatives (Tables 1 and 2).13) The values have been mea-
sured by Beedham et al. using partially purified human liver enzyme frac-
tions.13) Km, Vmax, the ratio of Vmax/Km, 1/Km, and also the logarithm of these
parameters were used as the biological data in the stepwise regression analy-
ses against the structural parameters of the aldehyde oxidase substrates. The
structural parameters used in this study are all calculated rather than experi-
mentally derived parameters. These parameters are easily obtainable even
for complex molecules and they can predict activity of compounds a priori.
The structures were optimized using both the COSMIC force field14) and, for
quantum mechanical parameters, the AM1 semiempirical method. Structural
parameters were generated mainly by MOPAC 7.0 for PC and also by molec-
ular mechanical methods. The parameters were atomic charges on certain
atoms in the main structure, the most positive and the most negative atomic
charges on the substituents, molecular weight, energies of the highest occu-
pied and the lowest unoccupied molecular orbitals, solvent accessible sur-
face area calculated using the probe of 1.4 Å radius on the van der Waals
surface of molecules, the highest and the lowest electrostatic potentials on
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enzyme. This finding and also the relationships of 1/Km of phthalazines with the energy of the lowest unoccupied
molecular orbital and log Vmax/log Km of phthalazines with degree of bonding of the two nitrogen atoms in the
molecules are consistent with the mechanism of action. The reaction involves a nucleophilic attack on an elec-
tron-deficient sp2-hybridized carbon atom and formation of an epoxide intermediate following the disruption of
the aromatic structure.
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Chart 1. The Oxidation of Phthalazine (a) and Quinazoline (b)
the solvent accessible surface of the molecule, dipole moments (calculated
by the semiempirical AM1 method and also from charge-2 method), maxi-
mum interatomic distances between the substituents and the carbon atoms to
which these are substituted, relevant degrees of bonding, and also indicator
variables for hydrogen bonding donor and acceptor ability in the sub-
stituents. For phthalazines, molar volume, heat of vaporization and cohesive
energy density were also calculated using the group contributions of
Fedors.15) The phthalazine and quinazoline derivatives were studied sepa-
rately. In addition, the whole molecule parameters were extracted and em-
ployed to analyze the two groups of compounds together. Multiple regres-
sion and stepwise regression analyses were performed using MINITAB sta-
tistical analysis software.
Results and Discussion
Phthalazine Derivatives Table 3 contains the values of
the structural parameters which were significantly correlated
with the biological data of phthalazines. The following equa-
tion resulted from the stepwise regression analysis with the
1/Km as the dependent variable:
1/Km520.133HBA20.36qR120.019m20.111ELUMO10.066 (1)
n514, r50.925, s50.016
where HBA is the indicator variable for hydrogen bonding
acceptor ability of the R1 substituent, qR1 is the atomic
charge on the first atom of R1 (calculated by the AM1
method), m is dipole moment calculated by the AM1 semi-
empirical method, and ELUMO is the energy of the lowest un-
occupied molecular orbital (the AM1 method). The numbers
of descriptors used in Eq. 1 is rather large for the 14 observa-
tions, but the t-ratios of the variables proved that they were
all statistically significant (the lowest t-ratio was 2.1 for
ELUMO ( p,0.05)).
Equation 1 shows clearly that polarity of compounds in-
creases the Km; this can be concluded from the negative coef-
ficients of both HBA and m . The relationship with ELUMO is
in agreement with the assumed mechanism of oxidation,
which involves a nucleophilic attack of the enzyme on the
molecule. Using Vmax and log Vmax/log Km as the dependent
variables in the stepwise regression analyses led to Eqs. 2
and 3.
Vmax520.101EHOMO20.0137dT20.702 (2)
n514, r50.902, s50.015
In this equation EHOMO is the energy of the highest occupied
molecular orbital and dT is cohesive energy density calcu-
lated for the whole molecule. The higher EHOMO values show
the easier availability of the electrons in the highest occupied
molecular orbital. Because the aromatic system is undergo-
ing a nucleophilic attack, the lower EHOMO will be desirable.
dT can be considered as a polarity parameter, which has a
negative effect on Vmax.
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Table 1. Phthalazine Derivatives Used in QSAR Equations and the Corresponding Km (mM) and Vmax (mM/min/mg) Values
Phthalazine 
R1 R5 R6 R7 Km
a) Vmax
a)
No.
P1 H H H H 41 0.107
P2 Cl H H H 9 0.068
P3 Cl H –OCH3 –OCH3 30 0.064
P4 –OC2H5 H H H 43 0.081
P5 –C6H5 H H H 9 0.047
P6 –OC6H5 H H H 150 0.018
P7 H H H 39 0.019
P8 H H H 35 0.006
P9 H H H 26 0.004
P10 H –OCH3 –OCH3 52 0.060
P11 –OCH3 –OCH3 –OCH3 130 0.019
P12 H –OCH3 –OCH3 23 0.029
P13 H –OCH3 –OCH3 220 0.033
P14 NHCH2CH2N(CH3)2 H H H 37 0.004
a) Data taken from ref. 13.
log Vmax/log Km5218.4DNN21.07qR6123.07 (3)
n514, r50.904, s50.171
where DNN is degree of bonding of the two nitrogen atoms in
the molecules and qR6 is the atomic charge on the first atom
of R6 (the AM1 method). The negative relationship with qR6
could be due to the better enzyme fitting of the compounds
with –OCH3 substituent (which can act as a possible hydro-
gen bond acceptor) in position 6 than those without a sub-
stituent. The negative slope for DNN is expected because
there is a bond breakage within the ring during the oxidation.
The relationships with log Vmax, log Km and log(Km/Vmax)
are not as good as the above mentioned correlations. For ex-
ample, log Km has a poor correlation with HBA (r50.578)
and the following is the equation with log Vmax which, again,
expresses the negative effect of polarity on Vmax:
log Vmax539.9qN220.31m18.58 (4)
n514, r50.897, s50.526
where m has been calculated from the charge-2 method16) and
qN2 is atomic charge on the N2 nitrogen atom, near R1. The
higher charges on the nitrogen atom indicate the greater elec-
tron withdrawing effect of the R1 substituent and conse-
quently the higher suitability of the ring to be subjected to
the nucleophilic attack.
Quinazoline Derivatives Considering the structures of
the quinazolines (Table 2), it is clear that there are two possi-
ble oxidation sites in the molecules, namely, C2 and C4 car-
bon atoms. In Q5—Q7 the C2 and in Q8—Q15 the C4 car-
bons are substituted and are no longer available for oxida-
tion. This means that the substrate binding to the enzyme is
performed in different manners for the two subsets. In the
case of Q1—Q4, with no substituent in any of the C2 or C4
positions, the decision cannot be made as to which class they
belong. Therefore, quinazolines with R4 substituent (Q8—
Q15) were first analyzed separately. The following equations
were obtained for the Q8—Q15:
(Vmax/Km) ·100050.0672sESP
1139.3q4210.8 (5)
n57, r50.887, s50.398
Km523.16sESP
11107 (6)
n56, r50.820, s514.75
log Km520.0372sESP
120.364HBA6,712.293 (7)
n56, r50.945, s50.241
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Table 2. Quinazoline Derivatives Used in QSAR Equations and the Corresponding Km (mM) and Vmax (mM/min/mg) Values
No. R2 R4 R6 R7 Km
a) Vmax
a)
Q1 H H H H 21 0.151
Q2 H H NH2 H 41 0.080
Q3 H H NO2 H 77 0.008
Q4 H H H NH2 140 0.009
Q5 CH3 H H H 15 0.071
Q6 H H H 15 0.008
Q7 H H H 400 0.018
Q8 H H H 300 0.054
Q9 H H H 78 0.025
Q10 H H H 35 0.048
Q11 H OCH3 H 10 0.015
Q12 H H OCH3 13 0.008
Q13 H OCH3 OCH3 33 0.004
Q14 H H H 43 0.004
Q15 H H H 17 0.030
a) Data taken from ref. 13.
in which sESP1 is the highest electrostatic potential on the
solvent accessible surface of the substituent R4, q4 is the
atomic charge on C4, and HBA6,7 is the indicator variable for
the presence of hydrogen bond acceptor ability in R6 or R7
substituents. The t-values for sESP1 and q4 in Eq. 5 and
sESP1 and HBA6,7 in equation 7 are 3.41 ( p,0.019), 4.03
( p,0.010), 4.38 ( p,0.012) and 3.75 ( p,0.020), respec-
tively, which show that despite the rather high ratio of struc-
tural parameters per observations used in these equations, the
independent variables are statistically significant. Q8 was an
outlier and was consequently deleted from Eqs. 6 and 7.
Equations 5—7 show that the higher electrostatic potential
on the R4 increases the enzyme activity. This could be due to
the higher electron withdrawing ability of the substituents
with high sESP1, which leads to the more nucleophilic C2
carbon, which is necessary for the oxidation process. Q8 is
an exception to this explanation, as, despite the high sESP1
value it has a high Km value. The positive coefficient of q4 in
Eq. 5, which is also due to the electron withdrawing nature of
the R4, is in accordance with this explanation. This was also
observed for the phthalazine series in which the R1 sub-
stituent was required to be electron withdrawing. However,
another explanation for the desirability of high sESP1 in sub-
strates could be the better enzyme binding of such com-
pounds through dipole–dipole interactions.
HBA6,7 has a negative coefficient in Eq. 7 which indicates
the better affinity of the enzyme to the substituents with H-
bonding acceptor ability. This result is in agreement with the
finding about phthalazine derivatives, which showed that ph-
thalazines with methoxyl substituent in a similar position (R6
and R7 in Table 1) were better substrates of aldehyde oxidase
(Eq. 3). It is worthwhile to mention that addition of HBA6,7
as the second parameter to Eq. 6 increases the regression co-
efficient to r50.991.
When the four quinazoline derivatives without R2 or R4
substituents (Q1—Q4) were incorporated in the analyses, al-
though similar correlations with sESP1 still existed, the other
parameters worked better:
Km524.15sESP
127.16qH21899 (8)
n511, r50.725, s529.8
In the final stage, correlations, which could cover all the
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Table 3. Structural Parameters for Phthalazine Derivatives Used in the QSAR Equations
No. EHOMO ELUMO m (AM1) DNN qR1 qR6 qN2 dT m (Charge-2) HBA
P1 29.553 20.903 4.570 1.282 0.169 0.139 20.240 12.719 5.08 0
P2 29.573 21.149 4.999 1.303 0.036 0.143 20.230 14.686 5.32 0
P3 29.348 21.117 6.362 1.310 0.039 20.209 20.240 13.301 6.03 0
P4 29.110 20.710 3.216 1.292 20.203 0.138 20.264 11.984 4.10 1
P5 29.192 20.992 4.308 1.319 20.044 0.140 20.247 12.500 4.98 0
P6 29.053 20.833 3.280 1.295 20.161 0.140 20.263 12.553 4.31 1
P7 28.885 20.756 5.128 1.313 20.221 0.137 20.270 12.958 6.33 1
P8 28.608 20.839 4.515 1.337 20.252 0.140 20.290 13.626 7.17 1
P9 28.898 20.903 4.186 1.338 20.217 0.141 20.288 13.895 8.63 1
P10 29.117 20.997 5.461 1.315 20.215 20.211 20.272 12.200 4.69 1
P11 28.859 20.903 5.696 1.315 20.214 20.216 20.270 12.080 4.41 1
P12 28.592 20.893 4.041 1.312 20.230 20.211 20.273 11.154 4.60 1
P13 28.864 20.793 5.270 1.314 20.241 20.212 20.268 11.752 4.43 1
P14 28.614 20.733 4.070 1.322 20.262 0.139 20.294 11.642 5.41 1
The AM1 derived parameters are EHOMO and ELUMO, the highest occupied and the lowest unoccupied molecular orbital energies, respectively, m (AM1), dipole moment, DNN,
degree of bonding of the two nitrogen atoms, qR1 and qR6, the atomic charges on the first atoms of R1 and R6, respectively. HBA is hydrogen bonding acceptor indicator variable
for R1, and qN2 is the atomic charge on the N2 nitrogen atom calculated by the charge-2 method.
Table 4. Structural Parameters for Quinazoline Derivatives
No. q4 sESP
1 sESP2 qH2 R2R4
1 maxR D23 HBA6,7
Q1 0.123 23.952 3.967 0.1921 0.108 1.110 1.1963 0
Q2 0.112 19.424 0.253 0.1926 0.101 1.109 1.1968 1
Q3 0.124 30.669 8.785 0.2011 0.101 1.115 1.1978 1
Q4 0.116 19.911 20.963 0.1893 0.101 1.110 1.1995 1
Q5 0.123 23.582 216.506 — 0.100 2.176 1.1722 0
Q6 0.119 22.738 227.96 — 0.100 6.442 1.1710 0
Q7 0.123 162.583 62.441 — 0.638 6.079 1.1948 0
Q8 0.147 46.941 238.476 0.1923 0.329 3.483 1.2152 0
Q9 0.260 12.810 212.914 0.1893 0.108 5.334 1.2270 0
Q10 0.260 24.627 232.151 0.1897 0.108 11.502 1.2321 0
Q11 0.254 25.279 231.331 0.1923 0.108 11.572 1.2297 1
Q12 0.255 25.172 231.874 0.1913 0.108 11.485 1.2199 1
Q13 0.250 20.038 236.613 0.1916 0.108 11.510 1.2364 1
Q14 0.236 23.519 237.381 0.1912 0.205 9.3128 1.2256 0
Q15 0.267 32.956 236.233 0.1974 0.108 7.5413 1.2207 0
q4 is the atomic charge on C4, sESP
1 and sESP2 are the highest and the lowest electrostatic potentials on the solvent accessible surface of the R4 or R2 substituents, qH2 is the
atomic charge on the hydrogen atom connected to C2 (for the derivatives without an R2 substituent), R2R41 is the highest atomic charge on the R2 or R4 substituents, maxR is the
maximum interatomic distance between R4 substituent and the carbon atom to which it is connected, D23 is the bonding order between C2 and N3 atoms, and HBA6,7 is the indica-
tor variable for the hydrogen bonding basicity in R6 or R7 substituents.
quinazolines were sought. To this end, some of the parame-
ters needed to be redefined, for example, sESP1 and sESP2
are, respectively, the highest and the lowest electrostatic po-
tentials on the solvent accessible surface of the substituent
R4, or R2 (where there is no R4 substituent). The following
are informative correlations:
log Km50.0125sESP
211.73 (9)
n514, r50.764, s50.302
log Km52.54R2R4
120.086maxR113D23214.0 (10)
n515, r50.892, s50.252
Q8 was an outlier from the correlation between log Km and is
excluded from Eq. 9. In Eq. 10, R2R41 is the most positive
atomic charge (calculated by the charge-2 method) in R4 (or
R2 for Q5-Q7), maxR is the AM1 calculated maximum in-
teratomic distances between R4 substituent and the carbon
atom to which it is substituted (in the case of Q5—Q7, the
maximum distance between R2 substituent and C2 carbon is
intended), D23 is the bonding order between C2 and N3
atoms calculated by AM1. It can be seen in Table 4 that the
highest R2R41 value belongs to Q7, Q8, and Q14. These are
the compounds with hydrogen bonding donor ability, which,
presumably, is not favorable for enzyme binding (probably
because of the low lipophilicity of such compounds). The co-
efficient of maxR indicates that for this set of substrates the
longer chains are preferred. The relationship with the D23 is
in accordance with the mechanism of oxidation in which the
disruption of the aromaticity occurs; the smaller bond order
means that bond breaking requires less energy.
Equation 9 shows that the lower sESP2 values result in
lower Km values and better enzyme affinity. This could be a
result of stronger dipole–dipole interactions of such sub-
stituents (which have strong electronegative atoms) with the
active site of the enzyme. This reasoning could be correct
only if it is assumed that the R2 and R4 substituents of
quinazolines occupy the same place in the enzyme active
site. Another explanation, which does not need this assump-
tion, is the electron withdrawing effect of the electronegative
atoms in the substituents, which decrease the resonance elec-
tron donating property of the nitrogen atom of R4 in struc-
tures like Q9—Q15.
Phthalazine and Quinazoline Derivatives In order to
derive correlations for the combination of the R2 and R4
substituted quinazolines and also phthalazines (29 com-
pounds), it was assumed that the R2 substituent of quinazo-
line numbers 5, 6, and 7, the R4 substituent of the rest of the
quinazolines (Table 2) and the R1 substituent of the phtha-
lazines (Table 1) occupy the same place in the enzyme active
site; this was only necessary for substituent parameters. At-
tempts to generate equations covering both groups of com-
pounds were not successful. Aldehyde oxidase is able to oxi-
dize a wide range of substrates ranging from small molecules
such as pyridoxal12) to large and complex molecules like
methotrexate.6) To date, the detailed characteristics of the ac-
tive/binding site of this enzyme have not been fully under-
stood. However, it seems that the active/binding site of alde-
hyde oxidase has a marked flexibility allowing this enzyme
metabolize diverse compounds. Furthermore, different
isozymes have been found for aldehyde oxidase from differ-
ent sources.13,17—19) Although, only one major isozyme has
been reported in human liver fractions to date,13) the possible
existence of other isozymes of human liver cannot be ex-
cluded.
Conclusion
Based on the results obtained, electronegative atoms on R2
or R4 substituents of quinazolines (higher sESP1 and lower
sESP2) are favored by the enzyme, as they reduce electron
density on the c4 or c2, respectively. This relationship is con-
sistent with the mechanism of aldehyde oxidase action,
which involves a nucleophilic attack on an electron-deficient
sp2-hybridized carbon atom and consequently the disruption
of the aromatic structure. This conclusion is also supported
by the presence of q4 in Eq. 5 and D23 in Eq. 10. For the ph-
thalazine series the presence of qN in Eq. 4, ELUMO in Eq. 1
and EHOMO in Eq. 2 indicates a similar mechanism of action.
There was a correlation with maxR (Eq. 10) which can be
considered a steric parameter but this relationship may also
be a result of better electronic requirements of the longer
substituents and there is need for more evidence. According
to the results obtained, the polarity (hydrophilicity) of the
substrates expressed as dipole moment m or cohesive energy
density dT or HBA has a negative effect on the enzyme activ-
ity. The results of this study can also give clues about the
structure of the binding site of the enzyme. It was assumed
that R2 and R4 substituents of quinazolines and R1 sub-
stituent of phthalazines occupy the same region in the en-
zyme active site. Although we did not find strong evidence to
prove this assumption, there was no evidence to prove it
wrong either.
The most important parameters for phthalazines are hydro-
gen bonding basicity indicator variable (HBA) and the en-
ergy of HOMO, which are the first parameters to enter the re-
gression equation in stepwise-regression analysis with 1/Km
and Vmax (Eqs. 1 and 2). For the quinazoline series the high-
est electrostatic potential of the R4 or R2 substituents
(sESP1) appeared in most of the equations.
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